Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Journal article

Dixon P. et al, (2022), Genetics in Medicine

Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

Journal article

Dixon P. et al, (2022), Genetics in Medicine

Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article

Journal article

Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Journal article

Pollard S. et al, (2022), Value Health

Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer

Journal article

Lim E. et al, (2022), NEJM Evidence, 1

WHAT IS THE NET ADDED VALUE OF PERSONALISED MEDICINE? A SYSTEMATIC LITERATURE REVIEW

Conference paper

Vellekoop H. et al, (2022), VALUE IN HEALTH, 25, S75 - S75

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

Journal article

100,000 Genomes Project Pilot Investigators None. et al, (2021), N Engl J Med, 385, 1868 - 1880

Clinical utility of whole-genome sequencing in precision oncology.

Journal article

Rosenquist R. et al, (2021), Semin Cancer Biol

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Journal article

Pollard S. et al, (2021), European Journal of Human Genetics

Load More